Literature DB >> 22871080

Aggressiveness, sexuality, and obsessiveness in late stages of ALS patients and their effects on caregivers.

Anna Marconi1, Giulia Meloni, Federica Fossati, Christian Lunetta, Stefania Bastianello, Mario Melazzini, Paolo Banfi, Gabriella Rossi, Massimo Corbo.   

Abstract

Clinical experience has shown an increase of behavioural and mood symptoms, especially in the areas of aggressiveness, sexuality and obsessiveness, during the late stages of ALS. The lack of conclusive data concerning these symptoms prompted us to assess the psychological aspects of ALS patients in advanced stages of the disease. Moreover, we evaluated the personality of their caregivers in order to analyse the relationship between the pair. For these purposes, we studied 10 patients with ALS in late stages (tracheostomized for 36 months) and their caregivers using a questionnaire specifically elaborated for patients' communication limits. To assess the state of anxiety and depression of both patients and caregivers, we used the Hospital Anxiety and Depression Scale (HADS). To investigate caregivers' personality, we administered the Big Five Questionnaire (BFQ). Data showed a trend of aggression and high level of obsessiveness in ALS patients, associated with several clinical characteristics. High levels of anxiety emerged in both patients and caregivers. Regarding BFQ, caregivers obtained higher scores in the dimension of Conscientiousness and very low scores in Extraversion and Emotional Stability. In conclusion, the study showed a potential and considerable effect of the long duration of ALS on patients' personality and caregivers' distress.

Entities:  

Mesh:

Year:  2012        PMID: 22871080     DOI: 10.3109/17482968.2012.696658

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  2 in total

1.  Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Mikhail P Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Marina Yu Matveeva; Tatjana V Arshinova; Petr M Ponomarenko; Olga V Arkova; Natalia P Bondar; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

2.  mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms.

Authors:  Barbara Scherz; Roland Rabl; Stefanie Flunkert; Siegfried Rohler; Joerg Neddens; Nicole Taub; Magdalena Temmel; Ute Panzenboeck; Vera Niederkofler; Robert Zimmermann; Birgit Hutter-Paier
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.